DermEffects: Dr. Wei Jing Loo
1560 Hyde Park Road
London, ON N6H 5L5
(519) 472-8686 (Cosmetic Inquiries)
(519) 472-2929 (Medical Inquiries)
(519) 472-8484 (Fax)
Monday–Friday: 7 a.m.–3 p.m.

Research & Clinical Trials

Dr. Loo is an adjunct professor at the University of Western Ontario and is very familiar with the rigor needed to conduct research and clinical trials that produce valuable results.

Dr. Wei Jing Loo uses her expertise and extensive training to help advance the fields of medical and cosmetic dermatology through her London, Ontario, practice. Regulatory agencies such as Health Canada and the FDA in the United States require clinical research trials before approving new treatments, preventive procedures, or devices.

Dr. Loo is an adjunct professor at the University of Western Ontario and is very familiar with the rigor needed to conduct research and clinical trials that produce valuable results. She has published her work in many peer-reviewed journals and has presented her research at national and international meetings.

Dr. Loo is an adjunct professor at the University of Western Ontario and is very familiar with the rigor needed to conduct research and clinical trials that produce valuable results.

Dr. Loo and her staff follow strict protocols and regulations when conducting clinical research trials.

Patients interested in participating in a clinical trial, sometimes called clinical studies, can volunteer by contacting DermEffects. If you’re accepted to participate, you can also decide to withdraw at any time.

Other important information to know for patients who participate in clinical research trials include:

  • Your participation is voluntary.
  • All information about you remains confidential.
  • Before participating in a study, Dr. Loo or another member of the clinical research team will explain all the details about the study to patients, including any potential risks or benefits, and answer all questions.
  • Patients have as much time as necessary to decide if they want to participate.
  • Patients who decide to participate must sign a consent form. They will keep a copy of this consent form, which contains additional information about the clinical research trial.

An Elite Skincare Specialist

Dr. Loo is an experienced, board-certified dermatologist who established DermEffects with a vision of providing excellent cosmetic and medical skin care.

Meet Dr. Wei Jing Loo Request a Consultation

Every clinical research trial is submitted to an independent research ethics board for approval before the study can be performed.

If you’re interested in learning about current clinical research trials, please visit ResearchTrials.org.

Please note that a physician referral is required for all medical consultations and treatments. Medical consultations are a benefit of Ontario Health Insurance Plan (OHIP). Elective services offered at DermEffects are not covered by OHIP.

Active Clinical Trials

We are currently recruiting for the following studies:

Chronic Eczema Research Study (68 Weeks)

Men and women aged 18 to 75 with a clinical diagnosis of chronic atopic dermatitis (eczema) for at least two years, may qualify to participate in this study. Individuals must have moderate to severe disease, involving 10% or more of their body. To be eligible, participants must also have a recent history (within 12 months) of inadequate response to treatment with topical medications, or for whom topical treatments are otherwise medically inadvisable.

Participants will receive investigational medication via injection (either active study drug or placebo). Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last up to 68 weeks and involve about 30 visits to the study centre.

Email Tina Craig, Clinical Research Coordinator at DermEffects to register.

 

Adolescent and Adult Eczema Research Study

Adolescents and adults aged 12-75 years old with chronic eczema (atopic dermatitis), may qualify to participate. Individuals must have moderate to severe disease, involving 10% of their body surface area, with an onset of symptoms at least 3 years prior to study start. A history (within 6 months) of inadequate response to treatment with topical medications or systemic treatment, or for whom topical treatments are otherwise medically inadvisable, is also required.

Participants will receive investigational oral medication (active study drug) or placebo during the initial treatment period. During the extension period, those individuals who previously received placebo will receive active study drug. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 34 months and involve about 21 visits to the study centre.

Email Tina Craig, Clinical Research Coordinator at DermEffects to register.

Alopecia Areata (Hair Loss) Research Study (32 Weeks)

Adults between 18 and 65 years of age with moderate to severe alopecia areata (hair loss), may qualify to participate. Individuals must have 50% or more hair loss of the scalp, with a history of recurrence and spontaneous remission. Must have a current episode of hair loss lasting at least 6 months and not exceeding 10 years. Total disease duration greater than 10 years is permitted. Must not have a history or presence of hair transplants.

Participants will receive investigational oral medication (active study drug) in one of two doses. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 32 weeks and involve about 11 visits to the study centre.

Email Tina Craig, Clinical Research Coordinator at DermEffects to register.

Prurigo Nodularis Research Study (14 Weeks)

Adults aged 18 years and older with a diagnosis of Prurigo Nodularis, defined by the presence of at least ten itchy nodules secondary to chronic pruritus present on at least two different body surface areas (e.g. both arms, one arm and one leg, one arm and the anterior trunk, or anterior and posterior trunk) may qualify to participate.

Participants will receive investigational oral medication (active study drug or placebo that has no active ingredient).  This drug is not approved yet for any use in any country.  Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last up to 14 weeks and involve 7 visits to the study centre.  In addition, up to 2 visits will occur by telephone.

Email Tina Craig, Clinical Research Coordinator at DermEffects to register

9 Week Eczema (Atopic Dermatitis) Study

The purpose of this study is to assess the safety and effectiveness of an investigational medication cream compared to placebo (inactive substance) in the treatment of mild-to-moderate eczema.

People who have had a diagnosis of atopic dermatitis for at least 6 months and are aged 18 and older may qualify to receive study drug at no cost.  There is no cost to participate, and participants will receive compensation for travel related expenses.

In order to qualify, participants must have 5%-25% of their body surface area covered in eczema, excluding their palms, soles, and scalp.  This is equivalent to 5-25 palm sized patches, including fingers.

Participants will be asked to visit the study centre about 7 times over a period of about 9 weeks.

Email Tina Craig, Clinical Research Coordinator at DermEffects to register.

Plaque Psoriasis Research Study (32 Weeks)

Adults 18 years of age or older with a diagnosis of chronic plaque psoriasis (with or without psoriatic arthritis) for at least 6 months, may qualify to participate. Individuals must have plaque psoriasis covering 2% or more of their body, with mild to moderate disease at the time of study entry.

Eligible participants will receive investigational oral medication (active drug or placebo).  Study medication and study-related care will be provided at no cost.  Reimbursement for study-related expenses may be provided.

Study participation will last about 32 weeks and include about 12 visits to the study centre.

Email Tina Craig, Clinical Research Coordinator at DermEffects to register.

Adolescent and Adult Eczema Research Study

Adolescents and adults aged 12-75 years old with chronic eczema (atopic dermatitis), may qualify to participate. Individuals must have moderate to severe disease, involving 10% of their body surface area, with an onset of symptoms at least 2 years prior to study start. A history (within 6 months) of inadequate response to treatment with topical medications or systemic treatment, or for whom topical treatments are otherwise medically inadvisable, is also required.

Participants will receive investigational injection medication (active study drug) or placebo during the  treatment period. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Email Tina Craig, Clinical Research Coordinator at DermEffects to register.

Hand Eczema Research Study (40 Weeks)

Adults aged 18 to 75 years old with severe chronic hand eczema (CHE), may qualify to participate. Individuals must have a history of severe CHE for at least 6 months and a body mass index (BMI) of 35 kg/m2 or less. Hand eczema resistant to high potency or ultra-high potency topical corticosteroids used in the past year, is also required.

Participants will receive investigational oral medication (active study drug) or placebo during the initial treatment period (part A). During the second treatment period (part B), those individuals who previously received placebo will receive active study drug. Use of an emollient throughout the duration of the study is required. Investigational medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 40 weeks and involve about 13 visits to the study centre.

Email Tina Craig, Clincal Research Coordinator at DermEffects to register.

9 Week Eczema (Atopic Dermatitis) Study

The purpose of this study is to assess the safety and effectiveness of an investigational medication cream compared to placebo (inactive substance) in the treatment of mild-to-moderate eczema.

People who have had a diagnosis of atopic dermatitis for at least 6 months and are aged 18 and older may qualify to receive study drug at no cost.  There is no cost to participate, and participants will receive compensation for travel related expenses.

In order to qualify, participants must have 1%-15% of their body surface area covered in eczema, excluding their palms, soles, and scalp.  This is equivalent to 1-15 palm sized patches, including fingers.

Participants will be asked to visit the study centre about 7 times over a period of about 9 weeks.

Email Tina Craig, Clincal Research Coordinator at DermEffects to register.

Psoriasis Research Study Testing a Cream (12 weeks)

The purpose of this study is to assess the safety, effectiveness and tolerability of an investigational cream compared to placebo (inactive substance) over 12 weeks in individuals with chronic plaque psoriasis involving 2 – 20% of their body.

Men and women who have had plaque psoriasis for at least 6 months and are aged 18 and older may qualify to receive study drug at no cost. There is no cost to participate, and participants will receive compensation for study-related expenses.

Email Tina Craig, Clincal Research Coordinator at DermEffects to register.

Plaque Psoriasis Oral Medication Study (24 Weeks)

Adults 18-75 years of age with chronic plaque psoriasis for at least 6 months, may qualify to participate. Eligible participants must have plaque psoriasis covering at least 10% of their body, with moderate to severe disease at the time of study entry.
Participants will receive investigational oral medication (active drug or placebo). Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last up to 24 weeks and include about 11 visits to the study centre.

Email Tina Craig, Clincal Research Coordinator at DermEffects to register.

Hidradenitis Suppurativa Research Study (16 Weeks)

Men and women aged 18-75 years old with a diagnosis of hidradenitis suppurativa (HS) and disease lasting for at least 6 months, may qualify to participate in this study. Individuals must have moderate to severe hidradenitis suppurativa with lesions in at least 2 distinct areas.  A stable course of HS for at least 90 days before screening, will be determined by the study doctor.

Eligible participants will receive investigational oral medication (active drug or placebo).  Study medication and study-related care will be provided at no cost.  Reimbursement for study-related expenses may be provided.

Study participation will last up to 16 weeks and include about 8 visits to the study centre.

Email Tina Craig, Clincal Research Coordinator at DermEffects to register.

Observational Psoriasis Research Study

You may qualify if you take pills, injections, infusions, or are receiving light therapy for psoriasis.  Participants must be 18 or older.  If you qualify, you’ll have regular visits with psoriasis specialists.  There is no cost to participate, and participants will receive reasonable compensation for travel or parking cost.

Participants will be asked to visit the study centre about 11 times over a 5 year period.

Email Tina Craig, Clincal Research Coordinator at DermEffects to register.